O	0	11	Progression
O	12	14	of
B-Symptom	15	25	geographic
I-Symptom	26	33	atrophy
O	34	36	in
B-Disease	37	40	age
I-Disease	40	41	-
I-Disease	41	48	related
I-Disease	49	56	macular
I-Disease	57	69	degeneration
O	70	76	imaged
O	77	81	with
B-Diagnostic_tool	82	90	spectral
I-Diagnostic_tool	91	97	domain
I-Diagnostic_tool	98	105	optical
I-Diagnostic_tool	106	115	coherence
I-Diagnostic_tool	116	126	tomography
O	126	127	.

O	129	131	To
O	132	141	determine
O	142	145	the
O	146	150	area
O	151	154	and
O	155	166	enlargement
O	167	171	rate
O	172	173	(
O	173	175	ER
O	175	176	)
O	177	179	of
B-Symptom	180	190	geographic
I-Symptom	191	198	atrophy
O	199	200	(
B-Symptom	200	202	GA
O	202	203	)
O	204	206	in
O	207	215	patients
O	216	220	with
B-Disease	221	224	age
I-Disease	224	225	-
I-Disease	225	232	related
I-Disease	233	240	macular
I-Disease	241	253	degeneration
O	254	255	(
B-Disease	255	258	AMD
O	258	259	)
O	260	265	using
O	266	269	the
B-Diagnostic_tool	270	278	spectral
I-Diagnostic_tool	279	285	domain
I-Diagnostic_tool	286	293	optical
I-Diagnostic_tool	294	303	coherence
I-Diagnostic_tool	304	314	tomography
I-Diagnostic_tool	315	316	(
I-Diagnostic_tool	316	318	SD
I-Diagnostic_tool	318	319	-
I-Diagnostic_tool	319	322	OCT
I-Diagnostic_tool	322	323	)
I-Diagnostic_tool	324	330	fundus
I-Diagnostic_tool	331	336	image
O	336	337	.

O	338	349	Prospective
O	349	350	,
O	351	363	longitudinal
O	363	364	,
O	365	372	natural
O	373	380	history
O	381	386	study
O	386	387	.

O	388	394	Eighty
O	394	395	-
O	395	398	six
B-Anatomy	399	403	eyes
O	404	406	of
O	407	409	64
O	410	418	patients
O	419	423	with
O	424	425	â‰¥
O	425	426	6
O	427	433	months
O	434	436	of
O	437	443	follow
O	443	444	-
O	444	446	up
O	446	447	.

O	448	456	Patients
O	457	461	with
B-Symptom	462	464	GA
O	465	474	secondary
O	475	477	to
B-Disease	478	481	AMD
O	482	486	were
O	487	495	enrolled
O	496	498	in
O	499	503	this
O	504	509	study
O	509	510	.

B-Diagnostic_tool	511	518	Macular
I-Diagnostic_tool	519	524	scans
O	525	529	were
O	530	539	performed
O	540	545	using
O	546	549	the
B-Diagnostic_tool	550	556	Cirrus
I-Diagnostic_tool	557	559	SD
I-Diagnostic_tool	559	560	-
I-Diagnostic_tool	560	563	OCT
O	564	565	(
O	565	569	Carl
O	570	575	Zeiss
O	576	583	Meditec
O	583	584	,
O	585	591	Dublin
O	591	592	,
O	593	595	CA
O	595	596	)
O	596	597	.

O	598	601	The
O	602	607	areas
O	608	610	of
B-Symptom	611	613	GA
O	614	624	identified
O	625	627	on
O	628	631	the
B-Diagnostic_tool	632	634	SD
I-Diagnostic_tool	634	635	-
I-Diagnostic_tool	635	638	OCT
I-Diagnostic_tool	639	645	fundus
I-Diagnostic_tool	646	652	images
O	653	657	were
O	658	668	quantified
O	669	674	using
O	675	676	a
O	677	687	digitizing
O	688	694	tablet
O	694	695	.

O	696	711	Reproducibility
O	712	714	of
O	715	720	these
O	721	733	measurements
O	734	737	was
O	738	746	assessed
O	747	750	and
O	751	754	the
O	755	757	ER
O	758	760	of
B-Symptom	761	763	GA
O	764	767	was
O	768	778	calculated
O	778	779	.

O	780	783	The
O	784	794	usefulness
O	795	797	of
O	798	808	performing
O	809	815	square
O	816	820	root
O	821	836	transformations
O	837	839	of
O	840	843	the
O	844	850	lesion
O	851	855	area
O	856	868	measurements
O	869	872	was
O	873	881	explored
O	881	882	.

O	883	894	Enlargement
O	895	899	rate
O	900	902	of
B-Symptom	903	905	GA
O	905	906	.

O	907	909	At
O	910	918	baseline
O	918	919	,
O	920	922	27
O	922	923	%
O	924	926	of
B-Anatomy	927	931	eyes
O	932	935	had
O	936	937	a
O	938	944	single
O	945	949	area
O	950	952	of
B-Symptom	953	955	GA
O	955	956	.

O	957	960	The
O	961	965	mean
O	966	971	total
O	972	976	area
O	977	979	at
O	980	988	baseline
O	989	992	was
O	993	994	4
O	994	995	.
O	995	997	59
O	998	1000	mm
O	1000	1001	(
O	1001	1002	2
O	1002	1003	)
O	1004	1005	(
O	1005	1006	1
O	1006	1007	.
O	1007	1008	8
O	1009	1013	disc
O	1014	1019	areas
O	1020	1021	[
O	1021	1023	DA
O	1023	1024	]
O	1024	1025	)
O	1025	1026	.

O	1027	1030	The
O	1031	1035	mean
O	1036	1042	follow
O	1042	1043	-
O	1043	1045	up
O	1046	1050	time
O	1051	1054	was
O	1055	1056	1
O	1056	1057	.
O	1057	1059	24
O	1060	1065	years
O	1065	1066	.

O	1067	1082	Reproducibility
O	1082	1083	,
O	1084	1086	as
O	1087	1095	assessed
O	1096	1100	with
O	1101	1104	the
O	1105	1115	intraclass
O	1116	1127	correlation
O	1128	1139	coefficient
O	1140	1141	(
O	1141	1144	ICC
O	1144	1145	)
O	1145	1146	,
O	1147	1150	was
O	1151	1160	excellent
O	1161	1163	on
O	1164	1168	both
O	1169	1172	the
O	1173	1181	original
O	1182	1186	area
O	1187	1192	scale
O	1193	1194	(
O	1194	1197	ICC
O	1198	1199	=
O	1200	1201	0
O	1201	1202	.
O	1202	1205	995
O	1205	1206	)
O	1207	1210	and
O	1211	1214	the
O	1215	1221	square
O	1222	1226	root
O	1227	1232	scale
O	1233	1234	(
O	1234	1237	ICC
O	1238	1239	=
O	1240	1241	0
O	1241	1242	.
O	1242	1245	996
O	1245	1246	)
O	1246	1247	.

O	1248	1259	Intergrader
O	1260	1271	differences
O	1272	1276	were
O	1277	1280	not
O	1281	1283	an
O	1284	1293	important
O	1294	1300	source
O	1301	1303	of
O	1304	1315	variability
O	1316	1318	in
O	1319	1325	lesion
O	1326	1330	size
O	1331	1342	measurement
O	1343	1344	(
O	1344	1347	ICC
O	1348	1349	=
O	1350	1351	0
O	1351	1352	.
O	1352	1355	999
O	1355	1356	,
O	1357	1358	0
O	1358	1359	.
O	1359	1362	997
O	1362	1363	)
O	1363	1364	.

O	1365	1367	On
O	1368	1375	average
O	1375	1376	,
O	1377	1380	the
O	1381	1383	ER
O	1384	1386	of
B-Symptom	1387	1389	GA
O	1390	1393	per
O	1394	1398	year
O	1399	1402	was
O	1403	1404	1
O	1404	1405	.
O	1405	1406	2
O	1407	1409	mm
O	1409	1410	(
O	1410	1411	2
O	1411	1412	)
O	1413	1414	(
O	1414	1415	0
O	1415	1416	.
O	1416	1418	47
O	1419	1421	DA
O	1421	1422	;
O	1423	1428	range
O	1428	1429	,
O	1430	1431	0
O	1431	1432	.
O	1432	1434	01
O	1434	1435	-
O	1435	1436	3
O	1436	1437	.
O	1437	1439	62
O	1440	1442	mm
O	1442	1443	(
O	1443	1444	2
O	1444	1445	)
O	1445	1446	/
O	1446	1450	year
O	1450	1451	)
O	1451	1452	.

O	1453	1456	The
O	1457	1459	ER
O	1460	1470	correlated
O	1471	1475	with
O	1476	1479	the
O	1480	1487	initial
O	1488	1492	area
O	1493	1495	of
B-Symptom	1496	1498	GA
O	1499	1500	(
O	1500	1501	r
O	1502	1503	=
O	1504	1505	0
O	1505	1506	.
O	1506	1508	45
O	1508	1509	;
O	1510	1511	P
O	1512	1513	<
O	1514	1515	0
O	1515	1516	.
O	1516	1519	001
O	1519	1520	)
O	1520	1521	,
O	1522	1525	but
O	1526	1531	there
O	1532	1536	were
O	1537	1545	variable
O	1546	1552	growth
O	1553	1558	rates
O	1559	1562	for
O	1563	1566	any
O	1567	1572	given
O	1573	1581	baseline
O	1582	1586	area
O	1586	1587	.

O	1588	1592	When
O	1593	1596	the
O	1597	1603	square
O	1604	1608	root
O	1609	1623	transformation
O	1624	1626	of
O	1627	1630	the
O	1631	1637	lesion
O	1638	1642	area
O	1643	1655	measurements
O	1656	1659	was
O	1660	1664	used
O	1665	1667	as
O	1668	1669	a
O	1670	1677	measure
O	1678	1680	of
O	1681	1687	lesion
O	1688	1692	size
O	1692	1693	,
O	1694	1697	the
O	1698	1700	ER
O	1701	1702	(
O	1702	1703	0
O	1703	1704	.
O	1704	1706	28
O	1707	1709	mm
O	1709	1710	/
O	1710	1712	yr
O	1712	1713	)
O	1714	1717	was
O	1718	1721	not
O	1722	1732	correlated
O	1733	1737	with
O	1738	1746	baseline
O	1747	1751	size
O	1752	1753	(
O	1753	1754	r
O	1755	1756	=
O	1757	1758	-
O	1758	1759	0
O	1759	1760	.
O	1760	1762	09
O	1762	1763	;
O	1764	1765	P
O	1766	1767	=
O	1768	1769	0
O	1769	1770	.
O	1770	1772	40
O	1772	1773	)
O	1773	1774	.

O	1775	1777	In
O	1778	1782	this
O	1783	1789	cohort
O	1790	1792	of
O	1793	1800	lesions
O	1800	1801	,
O	1802	1804	no
O	1805	1816	correlation
O	1817	1820	was
O	1821	1826	found
O	1827	1834	between
O	1835	1837	ER
O	1838	1841	and
O	1842	1848	length
O	1849	1851	of
O	1852	1858	follow
O	1858	1859	-
O	1859	1861	up
O	1861	1862	.

O	1863	1869	Square
O	1870	1874	root
O	1875	1889	transformation
O	1890	1892	of
O	1893	1896	the
O	1897	1901	data
O	1902	1908	helped
O	1909	1911	to
O	1912	1922	facilitate
O	1923	1929	sample
O	1930	1934	size
O	1935	1944	estimates
O	1945	1948	for
O	1949	1959	controlled
O	1960	1968	clinical
O	1969	1975	trials
O	1976	1985	involving
B-Symptom	1986	1988	GA
O	1988	1989	.

O	1990	1993	The
B-Diagnostic_tool	1994	1996	SD
I-Diagnostic_tool	1996	1997	-
I-Diagnostic_tool	1997	2000	OCT
I-Diagnostic_tool	2001	2007	fundus
I-Diagnostic_tool	2008	2013	image
O	2014	2017	can
O	2018	2020	be
O	2021	2025	used
O	2026	2028	to
O	2029	2038	visualize
O	2039	2042	and
O	2043	2051	quantify
B-Symptom	2052	2054	GA
O	2054	2055	.

O	2056	2066	Advantages
O	2067	2069	of
O	2070	2074	this
O	2075	2083	approach
O	2084	2091	include
O	2092	2095	the
O	2096	2107	convenience
O	2108	2111	and
O	2112	2121	assurance
O	2122	2124	of
O	2125	2130	using
O	2131	2132	a
O	2133	2139	single
O	2140	2147	imaging
O	2148	2157	technique
O	2158	2162	that
O	2163	2170	permits
O	2171	2183	simultaneous
O	2184	2197	visualization
O	2198	2200	of
B-Symptom	2201	2203	GA
O	2204	2209	along
O	2210	2214	with
O	2215	2218	the
B-Symptom	2219	2223	loss
I-Symptom	2224	2226	of
I-Symptom	2227	2241	photoreceptors
I-Symptom	2242	2245	and
I-Symptom	2246	2249	the
I-Symptom	2250	2257	retinal
I-Symptom	2258	2265	pigment
I-Symptom	2266	2276	epithelium
O	2277	2281	that
O	2282	2288	should
O	2289	2298	correlate
O	2299	2303	with
O	2304	2307	the
B-Symptom	2308	2312	loss
I-Symptom	2313	2315	of
I-Symptom	2316	2322	visual
I-Symptom	2323	2331	function
O	2331	2332	.
